Simplify Exchange Traded Funds (PINK) Stock Price, News & Analysis

Company Overview

Perimeter Medical Imaging AI Inc is a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address high unmet medical needs. The company is developing, with plans to commercialize, advanced imaging tools that allow surgeons, radiologists, and pathologists to visualize microscopic tissue structures during a clinical procedure.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: C$1.50
• Consensus Rating: Buy

PINK Stock Analysis - Frequently Asked Questions

How do I buy shares of Simplify Exchange Traded Funds?

Shares of PINK stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What other stocks do shareholders of Simplify Exchange Traded Funds own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Simplify Exchange Traded Funds investors own include DraftKings (DKNG), Walt Disney (DIS), Capri (CPRI), Clorox (CLX), First Trust Nasdaq Cybersecurity ETF (CIBR), Celsius (CELH) and Beyond (BYON).

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: N/A
• Industry: N/A
• Sub-Industry: N/A
• Current Symbol: TSE:PINK
• CIK: N/A
• Web: N/A
• Phone: N/A
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Simplify Exchange Traded Funds: C$1.50
• High Price Target: C$1.50
• Low Price Target: C$1.50
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A